Statements (42)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:drug
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Ciba-Geigy
|
gptkbp:brand |
Xanax
Alprazolam Intensol Alprazolam Oral Solution Niravam Xanax XR |
gptkbp:class |
anxiolytics
|
gptkbp:contraindication |
gptkb:sneaker
gptkb:Insurance_Company liver disease severe respiratory insufficiency |
gptkbp:developed_by |
gptkb:Upjohn_Company
|
gptkbp:duration |
6 to 12 hours
|
gptkbp:formulation |
gptkb:tablet
oral solution extended-release tablet |
https://www.w3.org/2000/01/rdf-schema#label |
Alprazolam
|
gptkbp:ingredients |
C23 H26 Cl N5
|
gptkbp:interacts_with |
gptkb:beer
opioids CY P3 A4 inhibitors |
gptkbp:is_atype_of |
N05 B A12
|
gptkbp:is_used_for |
anxiety
panic disorder |
gptkbp:legal_issue |
prescription only
|
gptkbp:lifespan |
11 hours
|
gptkbp:manager |
oral
|
gptkbp:metabolism |
liver
|
gptkbp:premiered_on |
1 hour
|
gptkbp:side_effect |
dizziness
fatigue drowsiness dry mouth memory impairment |
gptkbp:symptoms |
anxiety
seizures insomnia tremors |
gptkbp:type_of |
28981-97-7
|
gptkbp:year |
gptkb:1981
|